PMA device
Integra Artificial Skin, Dermal Regeneration Template
Integra Lifesciences Corp. · Device, Dermal Replacement (MDD, Class III) · First FDA decision May 4, 2012, newest May 4, 2012BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
47
Naming "Artificial Skin"
MAUDE reports
0
Brand "Artificial Skin", since 2015
PubMed studies
1,169
Mentioning "Artificial Skin"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Integra Artificial Skin, Dermal Regeneration Template
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- INTEGRA ARTIFICIAL SKIN, DERMAL REGENERATION TEMPLATEPMA supplement
P900033-S020 · Decided May 4, 2012 · 277 days after receipt · Normal 180 Day Track No User Fee
Device type: Device, dermal replacement (MDD) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Artificial Skin", any status and sponsor, newest update first.
- Skin Cancer Detection in Primary Care With and Without DermaSensorPivotal-lookingNot yet recruiting
DermaSensor, Inc.Not on our public-company list
NCT07940036 · 200 participants (planned) · Start Nov 10, 2026 · Primary completion Jun 2028
Device: DermaSensor · For: Skin Cancer; Basal Cell Cancer; Squamous Cell Carcinoma and 4 more
Sites: St Louis, Missouri
- Early- Warning and Precision-Intervention Technologies for Decline in Intrinsic CapacityPivotal-lookingNot yet recruiting
The Fourth Affiliated Hospital of Zhejiang University School of MedicineAcademic, hospital or other
NCT07938255 · 500 participants (planned) · Start Dec 31, 2026 · Primary completion Aug 31, 2028
Device: Multi-parameter Wearable Monitoring · For: Frailty at Older Adults
- Artificial Intelligence Assisted Innovative Low-cost Skin Testing Model to Accelerate Person-centered TB Prevention Services in Tanzania, Mozambique and UgandaPivotal-lookingNot yet recruiting
KNCV Tuberculosis FoundationAcademic, hospital or other
NCT07936643 · 1,804 participants (planned) · Start Apr 2027 · Primary completion Dec 2028
Device: SmartPatch reading using the TBConnect AI-assisted interpretation · For: Tuberculosis Infection, Latent; Tuberculosis Prevention
44 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Artificial Skin", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MDD
144 reports: 49 malfunction, 91 injury, 4 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1035-2009 · Started Jan 16, 2009 · Posted by FDA Mar 6, 2009
Reason given: Potential for open seals in the inner foil pouch of certain products. The outer seal remains intact and therefore the sterility of the inner pouch is maintained.
Cause as FDA categorized it: Pending · Device type: Device, Dermal Replacement (MDD)
Z-2328-2008 · Started Jul 2, 2008 · Posted by FDA Sep 20, 2008
Reason given: Product labeled with an expiration date on May 2010, while the actual expiration date should be April 2010.
Cause as FDA categorized it: Labeling mix-ups · Device type: Device, Dermal Replacement (MDD)
Published research
The most relevant PubMed records for "Artificial Skin"[tiab]. The summary above synthesizes these.
- Pursuing prosthetic electronic skin.
Chortos A, Liu J, Bao Z · Nat Mater · 2016Research Support, Non-U.S. Gov't, Review
- Artificial Skin Perception.
Wang M, Luo Y, Wang T, et al. · Adv Mater · 2021Review
- Artificial-goosebump-driven microactuation.
Zhang M, Pal A, Lyu X, et al. · Nat Mater · 2024
- Bioprinting for Skin.
Quílez C, de Aranda Izuzquiza G, García M, et al. · Methods Mol Biol · 2020Research Support, Non-U.S. Gov't
- 3D bioprinting of prefabricated artificial skin with multicomponent hydrogel for skin and hair follicle regeneration.
Ma X, Zhu X, Lv S, et al. · Theranostics · 2025
- Artificial skin.
Hall CW, Liotta D, De Bakey ME · Trans Am Soc Artif Intern Organs · 1966
- Artificial skin.
Föhn M, Bannasch H · Methods Mol Med · 2007
- Artificial skin.
Schulz JT, Tompkins RG, Burke JF · Annu Rev Med · 2000Review
- Programmable Artificial Skins Accomplish Antiscar Healing with Multiple Appendage Regeneration.
Xiong M, Yang X, Shi Z, et al. · Adv Mater · 2024Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- Artificial Skin Therapies; Strategy for Product Development.
Vaporidou N, Peroni F, Restelli A, et al. · Adv Wound Care (New Rochelle) · 2023
- Skin and Artificial Skin Models in Electrical Sensing Applications.
Ehtiati K, Eiler J, Bochynska A, et al. · ACS Appl Bio Mater · 2023Review, Research Support, Non-U.S. Gov't
- Advances in Spinal Cord Stimulation.
Lam CM, Latif U, Sack A, et al. · Bioengineering (Basel) · 2023Review
Other devices of this type
Also filed under product code MDD.
- Integra(R) Dermal Regeneration TemplateIntegra Lifesciences Corp. · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.